Related Experiment Videos
Effects of suramin on anastomotic colon tumors in a rat model
P Lauwers1, G Hubens, J Hendriks
1Laboratory for Experimental Surgery and Department of Immunology, 'Medisch Instituut Sint Augustinus', Antwerp, Belgium.
Background:
The development of antiangiogenic drugs offers new promise in the treatment of malignancy. Suramin has been reported to inhibit tumor growth by blocking angiogenesis and has been used in clinical trials. The aim of the present study was to examine the effects of suramin on colonic anastomotic tumors in the rat.
Methods:
(a) Colonic anastomotic tumor was induced in 120 WAG/RIJ rats. Half of the animals were given 100 mg/kg of suramin intraperitoneally at the time of tumor induction. Rats were sacrificed after 2, 4 and 8 weeks; tumor take and tumor weight were evaluated. (b) The number of red blood cell clusters per x 400 field was counted in each tumor. (c) A lymphocyte transformation test was performed in four groups of animals, 2 weeks before and 2 weeks after tumor implantation and/or suramin administration.
Results:
(a) A significant enhancement of tumor growth was observed in the suramin-treated animals. (b) This was accompanied by a significant increase in functional blood vessels. (c) Suramin-treated rats had markedly decreased lymphocyte stimulation, pointing to a possible immunosuppressive effect.
Conclusions:
The growth of an anastomotic colon tumor is rather enhanced by a single intraperitoneal administration of 100 mg/kg suramin in the rat, possibly by an unexpected immunosuppressive effect.
Insights
Suramin, an antiangiogenic drug, unexpectedly enhanced colon tumor growth in rats. This may be due to an immunosuppressive effect, increasing blood vessel formation and tumor progression.
Area of Science:
- Oncology
- Pharmacology
- Immunology
Background:
- Antiangiogenic drugs show promise for cancer treatment.
- Suramin inhibits tumor growth by blocking angiogenesis and has been used in clinical trials.
- The study investigates suramin's effect on colonic anastomotic tumors.
Purpose of the Study:
- To examine the effects of suramin on colonic anastomotic tumor growth in rats.
- To evaluate suramin's impact on tumor vascularization and host immune response.
Main Methods:
- Colonic anastomotic tumors were induced in 120 rats.
- Half received 100 mg/kg suramin intraperitoneally; tumor take and weight were assessed over 8 weeks.
- Red blood cell clusters and lymphocyte transformation were analyzed.
Main Results:
- Suramin significantly enhanced tumor growth and increased functional blood vessels.
- A marked decrease in lymphocyte stimulation was observed in suramin-treated rats, suggesting immunosuppression.
- Tumor take and weight were significantly higher in the suramin group.
Conclusions:
- Single-dose suramin administration enhanced anastomotic colon tumor growth in rats.
- This enhancement may be linked to an unexpected immunosuppressive effect of suramin.
- Further research is needed to understand suramin's complex role in tumor progression.